New drug combo aims to shrink fibroids in pregnant women
NCT ID NCT04762316
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a drug called SB-UF, which combines hormones and a plant extract, to see if it can shrink uterine fibroids in pregnant women. 66 women took the drug or a placebo throughout their pregnancy. The goal was to reduce fibroid size and help them disappear, which could make pregnancy safer and healthier.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- SB-UF (pregnenolone, pyridoxal phosphate, dydrogesterone, and Impatiens balsamina extract)
- What this could lead to
- If it works, this could offer a way to shrink uterine fibroids during pregnancy, potentially reducing complications and improving pregnancy outcomes.
- What could go wrong
- This is a small, completed Phase 4 trial with only 66 participants. Results may not apply to all women, and the combination of hormones and plant extracts may have side effects or limited effectiveness.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UTERINE FIBROIDS AFFECTING PREGNANCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Saigon Biopharma Company Limited
Ho Chi Minh City, 700000, Vietnam
More trials for these conditions
Other studies related to the condition(s) this trial covers.